跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
林 景堉
教授
,
醫學檢驗暨生物技術學系
合聘教授
,
醫學生物科技博士學位學程
合聘教授
,
癌症生物學與藥物研發博士學位學程
https://orcid.org/0000-0001-8269-797X
電子郵件
cylin
tmu.edu
tw
h-index
1385
引文
21
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1998 …
2024
每年研究成果
概覽
指紋
網路
專案
(10)
研究成果
(66)
資料集
(6)
類似的個人檔案
(6)
指紋
查看啟用 Ching-Yu Lin 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Immunology and Microbiology
Wart Virus
100%
Genotype
64%
Autoantibodies
60%
Inflammatory Arthritis
56%
Human Papillomavirus Type 16
32%
Isotype
27%
Immunoglobulin M
23%
Immunoglobulin A
21%
Human Papillomavirus Type 18
21%
Polymerase Chain Reaction
20%
Human Papillomavirus Type 52
18%
near Isogenic Line
17%
Blood Plasma
17%
Human Papillomavirus Type 58
15%
Prevalence
15%
Blood Level
15%
Polymerase Chain Reaction
14%
Molecular Cloning
13%
Northern Blotting
13%
Heavy Chain
12%
Autoimmune Disease
11%
Amino Acid Sequence
11%
Random Forest
10%
Inter-Alpha-Trypsin Inhibitor
10%
Squamous Cell
10%
Screening
9%
Coronary Artery
8%
Cell Motility
8%
Defensin
8%
Human Leukocyte Antigen
8%
Sjögren's Syndrome
8%
Salmonella Enterica Serovar Choleraesuis
8%
C1-Inhibitor
8%
Chicken Model
8%
Proteome Analysis
8%
Creatinine Blood Level
8%
Metabolite
8%
Methylation
8%
DNA Methylation
8%
Hepatitis B
8%
Integrin
8%
Antimicrobial Peptides
8%
Rhizoctonia solani
8%
Methylprednisolone
8%
Support Vector Machine
8%
Decision Trees
8%
Glycation
8%
Uterine Cervix
8%
Systemic Lupus Erythematosus
8%
GenBank
8%
Medicine and Dentistry
Wart Virus
82%
Genotype
46%
Neoplasm
39%
Proteomics
35%
Human Papillomavirus Type 16
30%
Papillomavirus Infection
26%
Polymerase Chain Reaction
22%
Cervical Cancer
20%
Human Papillomavirus Type 18
18%
Internal Medicine
17%
Rheumatoid Arthritis
17%
Autoantibodies
17%
Human Papillomavirus Type 52
17%
Infection
16%
Cervical Intraepithelial Neoplasia
15%
Human Papillomavirus Type 58
14%
Medicine
14%
Prevalence
13%
Rheumatology
13%
Division
13%
Immunology
13%
Cohort Analysis
11%
Prostate Cancer
10%
Ovarian Tumor
10%
Invasive Carcinoma
9%
Biological Marker
9%
Carcinoma in Situ
9%
Glioblastoma
8%
Cell Motility
8%
Uterine Cervix Carcinoma
8%
Neoadjuvant Chemotherapy
8%
Amyloid
8%
Glucose Regulated Protein 78
8%
Trypsin Inhibitor
8%
Leiomyosarcoma
8%
Malonaldehyde
8%
Computer Assisted Tomography
8%
Uterine Cervix
8%
Uterine Cervix Dysplasia
8%
Malignant Transformation
8%
Sigmoid
8%
Radical Surgery
8%
Human Leukocyte Antigen
8%
Ovarian Cancer
8%
Adenocarcinoma
8%
Bladder Cancer
8%
Heavy Chain
8%
Oxidative Phosphorylation
8%
Integrin
8%
Squamous Cell Carcinoma
5%
Biochemistry, Genetics and Molecular Biology
Autoantibodies
73%
Wart Virus
64%
Genotyping
35%
Immunoglobulin M
33%
Proteomics
31%
Posttranslational Modification
30%
Methylation
20%
Blood Level
20%
Human Papillomavirus Type 16
20%
Tandem Mass Spectrometry
19%
Human Papillomavirus Type 52
18%
Apolipoprotein
17%
Immunoglobulin A
16%
Human Papillomavirus Type 58
15%
Prevalence
15%
near Isogenic Line
13%
Random Forest
12%
Carcinogenesis
12%
Polymerase Chain Reaction
12%
Cohort Study
11%
Decision Trees
10%
Support Vector Machine
10%
Cancer Cell
10%
Glycoprotein
10%
Screening
9%
DNA Methylation
9%
Liquid Chromatography-Mass Spectrometry
9%
Serum Amyloid A1
8%
Oxidative Phosphorylation
8%
Serine
8%
Photobacterium damselae
8%
Protein Motif
8%
Acetylation
8%
Sex Hormone-Binding Globulin
8%
Hyperglycemia
8%
Arginine
8%
Metabolite
8%
Hemoglobin Blood Level
8%
Alpha 1-Antichymotrypsin
8%
Glycation
8%
Fecal Occult Blood
8%
Cell Motility
8%
C1-Inhibitor
8%
Apolipoprotein E
8%
Alanine
8%
RNA Recognition Motif
8%
Transaminase
8%
Antimicrobial Peptides
8%
Alkaline Phosphatase
8%
Creatinine Blood Level
8%
